Insider · CIK 0001952771
Nathaniel Calloway
Files at ANEB (Anebulo Pharmaceuticals, Inc.). First filing -, latest -.
Nathaniel Calloway files SEC Form 4 as director at ANEB (Anebulo Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Nathaniel Calloway has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 4, 2025 | ANEB Anebulo Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Apr 7, 2025 |
| Apr 4, 2025 | ANEB Anebulo Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +3,309 | $0.00 | $0 | 3,309 | Apr 7, 2025 |
Questions about Nathaniel Calloway
Answered from the filings on this page, as of the latest one.
Is Nathaniel Calloway buying or selling?
Nathaniel Calloway has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Nathaniel Calloway's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nathaniel Calloway has 0.
Where does Nathaniel Calloway file Form 4?
Nathaniel Calloway has filed Form 4 at ANEB (Anebulo Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.